Bill Text: SC H3823 | 2013-2014 | 120th General Assembly | Comm Sub
Bill Title: Drugs designated as schedule I, II, III, IV, and V controlled substances
Spectrum: Partisan Bill (Republican 2-0)
Status: (Introduced - Dead) 2014-01-15 - Recommitted to Committee on Judiciary [H3823 Detail]
Download: South_Carolina-2013-H3823-Comm_Sub.html
COMMITTEE REPORT
May 15, 2013
H. 3823
S. Printed 5/15/13--H. [SEC 5/16/13 3:01 PM]
Read the first time March 19, 2013.
To whom was referred a Bill (H. 3823) to amend Section 44-53-190, as amended, Sections 44-53-210, 44-53-230, 44-53-250, and 44-53-270, etc., respectfully
That they have duly and carefully considered the same and recommend that the same do pass:
F. GREGORY DELLENEY, JR. for Committee.
A BILL
TO AMEND SECTION 44-53-190, AS AMENDED, SECTIONS 44-53-210, 44-53-230, 44-53-250, AND 44-53-270, CODE OF LAWS OF SOUTH CAROLINA, 1976, RELATING, RESPECTIVELY, TO DRUGS DESIGNATED AS SCHEDULE I, II, III, IV, AND V CONTROLLED SUBSTANCES AND SECTION 44-53-1510, RELATING TO DRUGS DESIGNATED AS ANABOLIC STEROIDS, ALL SO AS TO ALPHABETIZE THESE LISTINGS AND TO ADD DRUGS TO THESE DESIGNATIONS TO CONFORM TO FEDERAL DRUG DESIGNATIONS AND DESIGNATIONS OF ADJACENT STATES IN ORDER TO ENHANCE AND IMPROVE ILLICIT DRUG ENFORCEMENT.
Be it enacted by the General Assembly of the State of South Carolina:
SECTION 1. Section 44-53-190 of the 1976 Code, as last amended by Act 140 of 2012, is further amended to read:
"Section 44-53-190. (A) The controlled substances listed in this section are included in Schedule I.
(B) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
1. Acetylmethadol
2. Allylprodine
3. Alphacetylmethadol
4. Alphameprodine
5. Alphamethadol
6. Benzethidine
7. Betacetylmethadol
8. Betameprodine
9. Betamethadol
10. Betaprodine
11. Clonitazene
12. Dextromoramide
13. [Deleted]
14. Diampromide
15. Diethylthiambutene
16. Dimenoxadol
17. Dimepheptanol
18. Dimethylthiambutene
19. Dioxaphetyl butyrate
20. Dipipanone
21. Ethylmethylthiambutene
22. Etonitazene
23. Etoxeridine
24. Furethidine
25. Hydroxypethidine
26. Ketobemidone
27. Levomoramide
28. Levophenacylmorphan
29. Morpheridine
30. Noracymethadol
31. Norlevorphanol
32. Normethadone
33. Norpipanone
34. Phenadoxone
35. Phenampromide
36. Phenomorphan
37. Phenoperidine
38. Piritramide
39. Proheptazine
40. Properidine
41. Racemoramide
42. Trimeperidine
43. Propiram
44. Difenoxin
45. Alfentanyl
46. Tilidine
47. Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine).
1. Acetyl-alpha-methylfentanyl
2. Acetylmethadol
3. Alfentanyl
4. Alphamethylfentanyl (N-[1-(alpha-methyl-beta-phenyl) ethyl-4-piperidyl] propionanilide; 1-(1-methyl-2-phenylethyl-4-(N-pro-panilido) piperidine)
5. Alpha-methylthiofentanyl
6. Allylprodine
7. Alphacetylmethadol
8. Alphameprodine
9. Alphamethadol
10. Benzethidine
11. Betacetylmethadol
12. Beta-hydroxyfentanyl
13. Beta-hydroxy-3-methylfentanyl
14 Betameprodine
15. Betamethadol
16. Betaprodine
17. Clonitazene
18. Dextromoramide
19. Diampromide
20. Diethylthiambutene
21. Difenoxin
22. Dimenoxadol
23. Dimepheptanol
24. Dimethylthiambutene
25. Dioxaphetyl butyrate
26. Dipipanone
27. Ethylmethylthiambutene
28. Etonitazene
29. Etoxeridine
30. Furethidine
31. Hydroxypethidine
32. Ketobemidone
33. Levomoramide
34. Levophenacylmorphan
35. 3-Methylfentanyl
36. 1-Methyl-4-phenyl-4-propionoxypiperidine (MPPP)
37. 3-Methylthiofentanyl
38. Morpheridine
39. Noracymethadol
40. Norlevorphanol
41. Normethadone
42. Norpipanone
43. Para-Fluorofentanyl
44. Phenadoxone
45. Phenampromide
46. 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine (PEPAP)
47. Phenomorphan
48. Phenoperidine
49. Piritramide
50. Proheptazine
51. Properidine
52. Propiram
53. Racemoramide
54. Thiofentanyl
55. Tilidine
56. Trimeperidine
(C) Any of the following opium derivatives, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
1. Acetorphine
2. Acetyldihydrocodeine
3. Benzylmorphine
4. Codeine methylbromide
5. Codeine-N-Oxide
6. Cyprenorphine
7. Desomorphine
8. Dihydromorphine
9. Etorphine
10. Heroin
11. Hydromorphinol
12. Methyldesorphine
13. Methylhydromorphine
14. Morphine methylbromide
15. Morphine methylsulfonate
16. Morphine-N-Oxide
17. Myrophine
18. Nicocodeine
19. Nicomorphine
20. Normorphine
21. Pholcodine
22. Thebacon
23. Drotebanol
1. Acetorphine
2. Acetyldihydrocodeine
3. Benzylmorphine
4. Codeine methylbromide
5. Codeine-N-Oxide
6. Cyprenorphine
7. Desomorphine
8. Dihydromorphine
9. Drotebanol
10. Etorphine
11. Heroin
12. Hydromorphinol
13. Methyldesorphine
14. Methylhydromorphine
15. Morphine methylbromide
16. Morphine methylsulfonate
17. Morphine-N-Oxide
18. Myrophine
19. Nicocodeine
20. Nicomorphine
21. Normorphine
22. Pholcodine
23. Thebacon
(D) Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
1. 3,4-methylenedioxy amphetamine
2. 5-methoxy-3,4-methylenedioxy amphetamine
3. 3,4-methylenedioxymethamphetamine (MDMA)
4. 3,4,5-trimethoxy amphetamine
5. Bufotenine
6. Diethyltryptamine (DET)
7. Dimethyltryptamine (DMT)
8. 4-methyl-2,5-dimethoxyamphetamine (STP)
9. Ibogaine
10. Lysergic acid diethylamide (LSD)
11. Marijuana
12. Mescaline
13. Peyote
14. N-ethyl-3-piperidyl benzilate
15. N-methyl-3-piperidyl benzilate
16. Psilocybin
17. Psilocyn
18. Tetrahydrocannabinol (THC)
19. 2,5-dimethoxyamphetamine
20. 4-bromo-2,5-dimethoxyamphetamine
21. 4-Methoxyamphetamine
22. Thiophene analog of phencyclidine
23. Parahexyl
24. Synthetic cannabinoids.--Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:
a. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.
b. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
c. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.
d. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
e. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.
f. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.
g. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.
h. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo [1,2,3-de]-1, 4-benzoxazin-6-yl]-1-napthalenylmethanone (WIN 55,212-2).
i. 9-(hydroxymethyl)-6,6-dimethy l-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).
j. Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by a alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.
(E) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:
(1) Mecloqualone;
(2) Methaqualone; or
(3) Gamma Hydroxybutyric Acid.
(F) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
(1) Fenethylline;
(2) N-ethylamphetamine;
(3) Cathinone; or
(4) Substituted Cathinones.
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
(a) by substitution in the phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b) by substitution at the 3-position with an alkyl substituent;
(c) by substitution at the nitrogen atom with alkyl or dialkyl groups, benzyl or methoxybenzyl groups; or
(d) by inclusion of the nitrogen atom in a cyclic structure.
Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone.
1. Alpha-ethyltryptamine (alpha-ET)
2. Alpha-methyltryptamine (AMT)
3. 4-bromo-2,5-dimethoxyamphetamine
4. 4-Bromo-2,5-dimethoxyphenethylamine (2C-B)
5. Bufotenine
6. 2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C-C)
7. Cyclohexamine (Ethylamine analog of phencyclidine, PCE)
8. Diethyltryptamine (DET)
9. 2,5-Dimethoxy-4-chloroamphetamine (DOC)
10. 2,5-Dimethoxy-4-iodoamphetamine (DOI)
11. 2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C-D)
12. 2,5-Dimethoxy-4-methylthiophenethylamine (2C-T)
13. 2,5-dimethoxyamphetamine
14. 2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C-E)
15. 2-(2,5-Dimethoxyphenyl) ethanamine (2C-H)
16. 2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C-I)
17. 2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C-N)
18. 2-(2,5-Dimethoxy-4-(n)-prophylphenyl) ethanamine (2C-P)
19. 2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-2)
20. 2-(4-ethylthio-2,5-dimethoxyphenyl) ethanamine (2C-T-4)
21. 2,5-Dimethoxy-4-(n)propylthiophenethylamine (2C-T-7)
22. 2,5-Dimethoxy-4-ethylamphetamine (DOE)
23. Dimethyltryptamine (DMT)
24. 5-Hydroxy-alpha-methyltryptamine (5-HO-aMT)
25. 5-Hydroxy-N-methyltryptamine (N-methylserotonin, norbufotenin)
26. 4-Hydroxy-N,N-diisopropyltryptamine (4-HO-DiPT)
27. 4-hydroxy-N-methyl-N-ethyltryptamine (4-HO-MET)
28. Ibogaine
29. 4-Iodo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25-I-NBOMe)
30. 5-Iodo-2-aminoindane (5-IAI)
31. Lysergic acid diethylamide (LSD)
32. Marijuana
33. Mescaline
34. Methoxetamine (MXE)
35. 5-Methoxy-alpha-methyltryptamine (5-MeO-AMT)
36. 4-Methoxyamphetamine
37. 3-Methoxy-4,5-methylenedioxyamphetamine (MMDA)
38. 5-Methoxy-N-methyl-N-isopropyltryptamine (5-MeO-MiPT, Moxy, Moxie)
39. 5 Methoxy-N,N,Dimethyltryptamine (5-MeO-DMT)
40. 5-Methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT)
41. 4-Methoxyphencyclidine (4-MeO-PCP, Methoxydine)
42. 4-Methyl-alpha-ethyltryptamine (4-methyl-aET)
43. Methylbenzodioxolybutanamine (MBDB)
44. 4-Methyl-2,5-dimethoxyamphetamine (STP)
45. 3,4-Methylenedioxyamphetamine (MDA)
46. 3,4-Methylenedioxy-N-ethylamphetamine (MDEA)
47. 5,6-Methylenedioxy-2-aminoindane (MDAI)
48. 3,4-Methylenedioxymethamphetamine (MDMA)
49. 5-Methyl-N,N-dimethyltryptamine (5-Me-DMT)
50. N-Ethyl-1-phenylcyclohexylamine (Eticyclidine)
51. N-ethyl-3-piperidyl benzilate
52. N-Hydroxy-3,4-methylenedioxyamphetamine (N-hydroxy MDA)
53. N-methyl-3-piperidyl benzilate
54. N-Methyltryptamine (Methyltryptamine, NMT)
55. N,N-diallyl-5-methoxytryptamine (5-MeO-DALT)
56. N,N-Diisopropyltryptamine(DiPT)
57. N,N-Dipropyltryptamine(DPT)
58. Parahexyl
59. Peyote
60. Psilocybin
61. Psilocyn
62. Rolicyclidine (Pyrrolidine analog of phencyclidine ,PHP, PCPy)
63. Synthetic cannabinoids. Any material, compound, mixture, or preparation that is not listed as a controlled substance in Schedule I through V, is not an FDA-approved drug, and contains any quantity of the following substances, their salts, isomers (whether optical, positional, or geometric), homologues, and salts of isomers and homologues, unless specifically excepted, whenever the existence of these salts, isomers, homologues, and salts of isomers and homologues is possible within the specific chemical designation:
a. Adamantoylindoles. Any compound containing a 3-(1-adamantoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the adamantyl ring system to any extent.
b. Benzoylindoles. Any compound containing a 3-(benzoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, AM-694, Pravadoline (WIN 48,098), RCS-4, AM-630, AM-1241, AM-2233.
c. Cyclohexylphenols. Any compound containing a 2-(3-hydroxycyclohexyl)phenol structure with substitution at the 5-position of the phenolic ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not substituted in the cyclohexyl ring to any extent. Including, but not limited to, CP 47,497 (and homologues), cannabicyclohexanol, CP-55, 940.
d. 2,3-Dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-
napthalenylmethanone (WIN 55,212-2).
e. 4-[4-(1,1-dimethylheptyl)-2,6-dimethoxyphenyl]-6,6-dimethyl-bicyclo[3.1.1] hept-2-ene-2-methanol (HU-308).
f. (6aR,9R,10aR)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,8,9,10,10a-hexahydrobenzo [c]chromene-1,9-diol (HU-243, Canbisol).
g. 3-hydroxy-2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-2,5-cyclohexadiene-1,4-dione (HU-331)
h. [(6S,6aR, 9R,10aR)-9-hydroxy-6-methyl-3-[(2R)-5-phenylpentan-2-yl]oxy-5,6,6a,7,8,9,10,10a-octahydrophenanthridin-1-yl] acetate (Levantradol, CP 50,556-1).
i. 9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol 7370 (HU-210, HU-211).
j. Indazole-3-carboxamides. Any compound containing an Indazole-3-carboxamide structure with substitution at the nitrogen atom of the indazole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to AKB-48, AB-FUBINACA, AB-PINACA.
k. Indole -3-carboxamides. Any compound containing an Indole-3-carboxamide structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl) ethyl group, whether or not further substituted in the indole ring to any extent. Including, but not limited, to STS-135.
l. Indole - 3-ylcycloalkyl ketones. Any compound containing an Indole-3-ylcycloalkyl ketone structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, (1-(N-methyl-2-piperidinyl)methyl, (tetrahydro-2H-pyran-4-yl)methyl or (morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent or whether or not substituted at the cycloalkyl ring to any extent. Including, but not limited to, XLR-11, UR-144, A-834735, A-796260, AB-001, AB-005.
m. 1-napthalenyl[4-(pentylox)-1-napthalenyl]-methanone (CB-13, CRA-13).
n. Naphthoylindoles. Any compound containing a 3-(1-naphthoyl)indole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-015, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-210, JWH-398, AM-2201, WIN 55-212, AM-2201 (C1 analog), AM-1220.
o. Naphthoylpyrroles. Any compound containing a 3-(1-naphthoyl)pyrrole structure with substitution at the nitrogen atom of the pyrrole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the pyrrole ring to any extent and whether or not substituted in the naphthyl ring to any extent. Including, but not limited to, JWH-307, JWH-370, JWH-176.
p. Naphthylmethylindoles. Any compound containing a 1H-indol-3-yl-(1-naphthyl)methane structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the naphthyl ring to any extent.
q. Naphthylmethylindenes. Any compound containing a naphthylideneindene structure with substitution at the 3-position of the indene ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indene ring to any extent and whether or not substituted in the naphthyl ring to any extent.
r. N-cyclopropyl-11-(3-hydroxy-5-pentylphenoxy)-undecanamide (CB-25).
s. N-cyclopropyl-11-(2-hexyl-5-hydroxyphenoxy)-undecanamide (CB-52).
t. N-cyclopropyl-8-[3-(1,1-dimethylheptyl)-5-hydroxyphenoxy]-octanamide (CB-86).
u. Phenylacetylindoles. Any compound containing a 3-phenylacetylindole structure with substitution at the nitrogen atom of the indole ring by an alkyl, haloalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 1-(N-methyl-2-piperidinyl)methyl, or 2-(4-morpholinyl)ethyl group, whether or not further substituted in the indole ring to any extent and whether or not substituted in the phenyl ring to any extent. Including, but not limited to, SR-18, RCS-8, JWH-203, JWH-250, JWH-251.
64. Tenocyclidine(1-[1-(2-Thienyl)cyclohexyl]piperidine, TCP)
65. Tetrahydrocannabinol (THC)
66. 1-[1-(2-Thienyl)cyclohexyl]pyrrolidine (TCPy)
67. Thiophene analog of phencyclidine
68. 3,4,5-trimethoxy amphetamine
(E) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance having a depressant effect on the central nervous system, including its salts, isomers, and salts of isomers if possible within the specific chemical designation:
1. Gamma Hydroxybutyric Acid
2. Mecloqualone
3. Methaqualone
(F) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers, and salts of isomers:
1. 2-Aminoindane (2-AI)
2. 6-(2-aminopropyl)benzofuran (6-APB)
3. Aminorex
4. Benocyclidine (BCP, BTCP)
5. Cathinone
6. 4-Chlorophenylisobutylamine (4-CAB)
7. 3-Chlorophenylpiperazine (mCPP)
8. 4-Chlorophenylpiperazine (pCPP)
9. 1,4-Dibenzylpiperazine (DBZP)
10. Fenethylline
11. 4-Fluoroamphetamine (4-FA)
12. 2-Fluoromethamphetamine (2-FMA)
13. 4-Fluoromethamphetamine (4-FMA)
14. 4-Fluorophenylpiperazine (pFPP)
15. Methiopropamine (MPA)
16. 2-Methoxyphenylpiperazine (oMeOPP)
17. 4-Methoxyphenylpiperazine (pMeOPP)
18. 4-Methylaminorex (cis isomer)
19. 1-Methyl-4-benzyl piperazine (MBZP)
20. 3,4-Methylenedioxy-1-benzylpiperazine (MDBZP)
21. 3-Methylphenylpiperazine (mMPP)
22. 4-Methylphenylpiperazine (pMPP)
23. N-Benzylpiperazine (BZP)
24. N-ethylamphetamine
25. N,N-Dimethylamphetamine (Metrotonin)
26. Substituted Cathinones
Any compound (not being bupropion) structurally derived from 2-amino-1-phenyl-1-propanone by modification in any of the following ways:
(a) by substitution in the phenyl ring to any extent with an alkyl, alkoxy, alkylenedioxy, haloalkyl or halide substituents, whether or not further substituted in the phenyl ring by one or more other univalent substituents;
(b) by substitution at the 3-position with an alkyl substituent;
(c) by substitution at the nitrogen atom with an alkyl or dialkyl groups, benzyl or methoxybenzyl groups, or alkanoyl groups; or
(d) by inclusion of the nitrogen atom in a cyclic structure.
Including, but not limited to: Methylone, Mephedrone, 3,4-Methylenedioxypyrovalerone (MDPV), Butylone, Methedrone, 4-Methylethcathinone, Flephedrone, Pentylone, Pentedrone, Buphedrone.
27. 3-Trifluoromethylphenylpiperazine (TFMPP)."
SECTION 2. Section 44-53-210 of the 1976 Code is amended to read:
"Section 44-53-210. (a) The controlled substances listed in this section are included in Schedule II.
(b) Any of the following substances except those narcotic drugs listed in other schedules whether produced directly or indirectly by extraction from substances of vegetable origin, or independently by means of chemical synthesis, or by combination of extraction and chemical synthesis:
(1) Opium and opiate, and any salt, compound, derivative, or preparation of opium or opiate, excluding Apomorphine, Nalbuphine, Naloxone, and Naltrexone, and their respective salts;
(2) Any salt, compound, isomer, derivative, or preparation thereof which is chemically equivalent or identical with any of the substances referred to in paragraph (1), but not including the isoquinoline alkaloids of opium;
(3) Opium poppy and poppy straw;
(4) Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances, but not including decocainized coca leaves or extractions which do not contain cocaine or ecgonine.
(c) Any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters and ethers, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:
1. Alphaprodine
2. Anileridine
3. Bezitramide
4. Dihydrocodeine
5. Diphenoxylate
6. Fentanyl
7. Isomethadone
8. Levomethorphan
9. Levorphanol
10. Metazocine
11. Methadone
12. Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane
13. Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
14. Pentazocine (to be administered by injection only)
15. Pethidine (meperidine).
16. Pethidine - Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine
17. Pethidine - Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
18. Pethidine - Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid
19. Phenazocine
20. Piminodine
21. Racemethorphan
22. Racemorphan
23. Dextropropoxyphene [alpha-(+" )-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane], in bulk form.
24. Sufentanil
1. Alfentanil
2. Alphaprodine
3. Anileridine
4. 4-Anilino-N-phenethyl-4-piperidine
5. Bezitramide
6. Dextropropoxyphene[alpha-(+)-4-dimethylamino-1,2-diphenyl-3-methyl-2-propionoxybutane], in bulk form
7. Dihydrocodeine
8. Dihydroetorphine
9. Diphenoxylate
10. Diprenorphine
11. Fentanyl
12. Isomethadone
13. Levo-alphacetylmethadol
14. Levomethorphan
15. Levorphanol
16. Metazocine
17. Methadone
18. Methadone - Intermediate, 4-cyano-2-dimethylamino-4, 4-diphenyl butane
19. Moramide - Intermediate, 2-methyl-3-morpholino-1, 1-diphenylpropane-carboxylic acid
20. Oripavine
21. Oxycodone
22. Pentazocine (to be administered by injection only)
23. Pethidine (meperidine).
24. Pethidine-Intermediate-A, 4-cyano-1-methyl-4-phenyl-piperidine
25. Pethidine-Intermediate-B, ethyl-4-phenylpiperidine-4-carboxylate
26. Pethidine-Intermediate-C, 1-methyl-4-phenylpiperidine-4-carboxylic acid
27. Phenazocine
28. Piminodine
29. Racemethorphan
30. Racemorphan
31. Remifentanil
32. Sufentanil
33. Tapentadol
34. Thebaine
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
1. Amphetamine, its salts, optical isomers, and salts of its optical isomers.
2. Methamphetamine, its salts, and salts of isomers.
3. Phenmetrazine and its salts.
4. Methylphenidate.
2. Lisdexamfetamine
3. Methamphetamine, its salts, and salts of isomers
4. Methylphenidate
5. Phenmetrazine and its salts
(e) [Deleted] Any material, compound, mixture, or preparation which contains any quantity of the following hallucinogenic substances, their salts, isomers, and salts of isomers, unless specifically excepted, whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
1. Nabilone
(f) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
1. Amobarbital
2. Secobarbital
3. Pentobarbital
4. Phencyclidine
5. Phencyclidine immediate precursors:
(a) 1-phenylcyclohexylamine
(b) 1-piperidinocyclohexanecarbonitrile (PCC).
2. Pentobarbital
3. Phencyclidine
4. Phencyclidine immediate precursors
(a) 1-phenylcyclohexylamine
(b) 1-piperidinocyclohexanecarbonitrile (PCC)
5. Secobarbital
(g) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substance:
(1) Immediate precursor to amphetamine and methamphetamine:
(i) Phenylacetone, also known as phenyl-2-propanone; P2P; benzyl methyl ketone; methyl benzyl ketone."
SECTION 3. Section 44-53-230 of the 1976 Code is amended to read:
"Section 44-53-230. (a) The controlled substances listed in this section are included in Schedule III.
(b) Any material, compound, mixture or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system:
1. Benzphetamine
2. Chlorphentermine
3. Clortermine
4. (Deleted)
5. Phendimetrazine
(c) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system:
1. any compound, mixture, or preparation containing amobarbital, secobarbital, pentobarbital or any salt thereof and one or more other active ingredients which are not listed in any schedule;
2. any suppository dosage form containing amobarbital, secobarbital, pentobarbital, or any salt of any of these drugs and approved by the United States Food and Drug Administration for marketing only as a suppository;
3. any substance which contains any quantity of a derivative or barbituric acid or any salt thereof;
4. Chlorhexadol;
5. Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act;
6. Glutehimide;
7. Lysergic Acid;
8. Lysergic Acid Amide;
9. Methyprylon;
10. Sulfondiethylmethane;
11. Sulfonethylmethane;
12. Sulfonmethane.
5. Embutramide
6. Gamma Hydroxybutyric Acid, and its salts, isomers, and salts of isomers contained in a drug product for which an application has been approved under Section 505 of the Federal Food, Drug and Cosmetic Act;
7. Glutethimide;
8. Ketamine;
9. Lysergic Acid;
10. Lysergic Acid Amide;
11. Methyprylon;
12. Sulfondiethylmethane;
13. Sulfonethylmethane;
14. Sulfonmethane;
15. Tiletamine & Zolazepam Combination Product.
(d) Nalorphene.
(e) Any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
1. not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with an equal or greater quantity of an isoquinoline alkaloid of opium.;
2. not more than 1.8 grams of codeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
3. not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with a four-fold or greater quantity of an isoquinoline alkaloid of opium.;
4. not more than 300 milligrams of dihydrocodeinone per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
5. not more than 1.8 grams of dihydrocodeine per 100 milliliters or not more than 90 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
6. not more than 300 milligrams of ethylmorphine per 100 milliliters or not more than 15 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
7. not more than 500 milligrams of opium per 100 milliliters or per 100 grams, or not more than 25 milligrams per dosage unit, with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
8. not more than 50 milligrams of morphine per 100 milliliters or per 100 grams with one or more active, non-narcotic nonnarcotic ingredients in recognized therapeutic amounts.;
9. Buprenorphine;
10. o-Desmethyltramadol;
11. Tramadol;
(f) Dronabinol in sesame oil and encapsulated in a soft gelatin capsule."
SECTION 4. Section 44-53-250 of the 1976 Code is amended to read:
"Section 44-53-250. The controlled substances in this section are included in Schedule IV.
(a) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Alprazolam
(2) Barbital
(3) Bromazepam
(4) Camazepam
(5) Chloral Betaine
(6) Chloral Hydrate
(7) Chlordiazepoxide
(8) Clobazam
(9) Clonazepam
(10) Clorazepate
(11) Clotiazepam
(12) Cloxazolam
(13) Delorazepam
(14) Diazepam
(15) Estazolam
(16) Ethchlorvynol
(17) Ethinamate
(18) Ethyl Loflazepate
(19) Fludiazepam
(20) Flunitrazepam
(21) Flurazepam
(22) Halazepam
(23) Haloxazolam
(24) Ketazolam
(25) Loprazolam
(26) Lorazepam
(27) Lormetazepam
(28) Mebutamate
(29) Medazepam
(30) Meprobamate
(31) Methohexital
(32) Methylphenobarbital
(33) Nimetazepam
(34) Nitrazepam
(35) Nordiazepam
(36) Oxazepam
(37) Oxazolam
(38) Paraldehyde
(39) Petrichloral
(40) Phenobarbital
(41) Pinazepam
(42) Prazepam
(43) Temazepam
(44) Tetrazepam
(45) Triazolam.
1. Alprazolam
2. Barbital
3. Bromazepam
4. Camazepam
5. Chloral Betaine
6. Chloral Hydrate
7. Chlordiazepoxide
8. Clobazam
9. Clonazepam
10. Clorazepate
11. Clotiazepam
12. Cloxazolam
13. Delorazepam
14. Diazepam
15. Dichloralphenazone
16. Estazolam
17. Ethchlorvynol
18. Etizolam
19. Ethinamate
20. Ethyl Loflazepate
21. Fludiazepam
22. Flunitrazepam
23. Flurazepam
24. Fospropofol
25. Halazepam
26. Haloxazolam
27. Ketazolam
28. Loprazolam
29. Lorazepam
30. Lormetazepam
31. Mebutamate
32. Medazepam
33. Meprobamate
34. Methohexital
35. Methylphenobarbital
36. Midazolam
37. Nimetazepam
38. Nitrazepam
39. Nordiazepam
40. Oxazepam
41. Oxazolam
42. Paraldehyde
43. Petrichloral
44. Phenazepam
45. Phenobarbital
46. Pinazepam
47. Prazepam
48. Pyrazolam
49. Quazepam
50. Temazepam
51. Tetrazepam
52. Triazolam.
53. Zaleplon
54. Zolpidem
55. Zopiclone
(b) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
(1) Diethylpropion
(2) Mazindol
(3) Phentermine
(4) Pemoline, including organometallic complexes and chelates thereof
(5) Pipradol
(6) SPA [(-)-1-Dimethylamino-1, 2-diphenylethane].
1. Cathine
2. Diethylpropion
3. Fencamfamin
4. Fenproporex
5. Mazindol
6. Mefenorex
7. Modafinil
8. Phentermine
9. Pemoline, including organometallic complexes and chelates thereof
10. Pipradol
11. Sibutramine.
12. SPA [(-)-1-Dimethylamino-1, 2-diphenylethane]
(c) Any material, compound, mixture or preparation containing any quantity of the following substance, including its salts, isomers (whether position, geometric, or optical) and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible:
(1) Fenfluramine.
(d) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following substances, including its salts;:
(1) [Blank] (Reserved)
(e) Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, or any salts thereof:
(1) not more than one milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.
(2) dosage forms of Dextropropoxyphene [Alpha-(+)-4-dimethylamino-1, 2-diphenyl-3-methyl-2-propionoxybutane].
(f) Pentazocine hydrochloride and acetaminophen, pentazocine hydrochloride and aspirin, and pentazocine and naloxone hydrochloride (all for oral administration only).
(g) Butorphanol"
SECTION 5. Section 44-53-270 of the 1976 Code is amended to read:
"Section 44-53-270. (a) The controlled substances listed in this section are included in Schedule V.
(b) Any compound, mixture, or preparation containing limited quantities of any of the following narcotic drugs, which shall include includes one or more non-narcotic nonnarcotic active medicinal ingredients in sufficient proportion to confer upon the compound, mixture, or preparation, valuable medicinal qualities other than those possessed by the narcotic drug alone:
(1) not more than 200 milligrams of codeine per 100 milliliter or per 100 grams;
(2) not more than 100 milligrams of dihydrocodeine per 100 milliliters or per 100 grams;
(3) not more than 100 milligrams of ethylmorphine per 100 milliliters or per 100 grams;
(4) not more than 2.5 milligrams of diphenoxylate and not less than 25 micrograms of atropine sulfate per dosage unit;
(5) not more than 100 milligrams of opium per 100 milliliters or per 100 grams.;
(6) not more than one-half milligram of difenoxin and not less than twenty-five micrograms of atropine sulfate per dosage unit.
(c) Depressants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a depressant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
1. Lacosamide
2. Pregabalin
(d) Stimulants. Unless specifically excepted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including its salts, isomers (whether position, geometric, or optical), and salts of such isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation:
1. Pyrovalerone"
SECTION 6. Section 44-53-1510 of the 1976 Code is amended to read:
"Section 44-53-1510. (A) The term 'anabolic steroid' includes any of the following or any isomer, ester, salt, or derivative of the following that acts in the same manner on the human body:
(1) clostebol;
(2) dehydrochlormethyltestosterone;
(3) ethylestrenol;
(4) fluoxymesterone;
(5) mesterolone;
(6) methandienone;
(7) methandrostenolone;
(8) methenolone;
(9) methyltestosterone;
(10) nandrolone;
(11) norethandrolone;
(12) oxandrolone;
(13) oxymesterone;
(14) oxymetholone;
(15) stanozolol; and
(16) testosterone.
1. 3-alpha,17beta-dihydroxy-5alpha-androstane
2. 17-alpha-methyl-3alpha,17beta-dihydroxy-5alpha-androstane
3. 17-alpha-methyl-3beta,17beta-dihydroxy-5alpha-androstane
4. 17-alpha-methyl-3beta,17beta-dihydroxyandrost-4-ene
5. 17-alpha-methyl-4-hydroxynandrolone
6. 17-alpha-methyl-delta1-dihydrotestosterone
7. androstanedione
8. 1-androstenediol
9. 4-androstenediol
10. 5-androstenediol
11. 1-androstenedione
12. 4-androstenedione
13. 5-androstenedione
14. 3-beta,17beta-dihydroxy-5alpha-androstane
15. 13-beta-ethyl-17beta-hydroxygon-4-en-3-one
16. bolasterone
17. boldenone
18. boldione
19. calusterone
20. clostebol
21. dehydrochlormethyltestosterone
22. delta1-dihydrotestosterone
23. desoxymethyltestosterone
24. 4-dihydrotestosterone
25. drostanolone
26. ethylestrenol
27. fluoxymesterone
28. formebolone
29. furazabol
30. 4-hydroxy-19-nortestosterone
31. 4-hydroxytestosterone
32. mestanolone
33. esterolone
34. methandienone
35. methandriol
36. methandrostenolone
37. methenolone
38. methyldienolone
39. methyltestosterone
40. methyltrienolone
41. mibolerone
42. nandrolone
43. 19-nor-4,9(10)-androstadienedione
44. 19-nor-4-androstenediol
45. 19-nor-4-androstenedione
46. 19-nor-5-androstenediol
47. 19-nor-5-androstenedione
48. norbolethone
49. norclostebol
50. norethandrolone
51. normethandrolone
52. oxandrolone;
53. oxymesterone
54. oxymetholone
55. prostanozol
56. stanozolol
57. stenbolone
58. testolactone
59. testosterone
60. tetrahydrogestrinone
61. trenbolone
(B) Anabolic steroids that are expressly intended for administration through implants to cattle or other nonhuman species, and that are approved by the federal Food and Drug Administration for this use, are not considered anabolic steroids as defined by this article and are not governed by its provisions."
SECTION 7. This act takes effect upon approval by the Governor.
